These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38843661)

  • 1. Prognostic characteristics, recurrence patterns, and survival outcomes of vulval squamous cell carcinoma - A twelve-year retrospective analysis of a tertiary centre.
    Darwish A; Ismail L; Manek S; Hellner K; Kehoe S; Soleymani Majd H
    Eur J Surg Oncol; 2024 Jul; 50(7):108447. PubMed ID: 38843661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multivariate analysis of prognostic factors in primary squamous cell vulvar cancer: The role of perineural invasion in recurrence and survival.
    Ferrari F; Forte S; Ardighieri L; Bonetti E; Fernando B; Sartori E; Odicino F
    Eur J Surg Oncol; 2019 Nov; 45(11):2115-2119. PubMed ID: 31378417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors for local recurrence of squamous cell carcinoma of the vulva: A systematic review.
    Te Grootenhuis NC; Pouwer AW; de Bock GH; Hollema H; Bulten J; van der Zee AGJ; de Hullu JA; Oonk MHM
    Gynecol Oncol; 2018 Mar; 148(3):622-631. PubMed ID: 29137809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vulvar cancer recurrence - an analysis of prognostic factors in tumour-free pathological margins patients group.
    Minar L; Felsinger M; Cihalova M; Zlamal F; Bienertova-Vasku J
    Ginekol Pol; 2018; 89(8):424-31. PubMed ID: 30215461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inguino-femoral radiotherapy in vulvar squamous cell carcinoma: clues to revised indications in patients with only one intracapsular lymph node metastasis.
    Serre E; Raimond E; Diguisto C; Bendifallah S; Body G; Touboul C; Graesslin O; Carcopino X; Daraï E; Ouldamer L;
    Acta Oncol; 2020 May; 59(5):518-524. PubMed ID: 31718368
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of re-excision of residual adjacent vulvar intraepithelial neoplasia (VIN III) and histological tumour-free margin (hTFM) on survival in primary squamous cell carcinoma of vulva.
    Gasimli K; Straussner M; Schmeil I; Karn T; Winkelmann R; Becker S; El-Balat A
    Arch Gynecol Obstet; 2018 Nov; 298(5):945-950. PubMed ID: 30187190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stage IA vulvar squamous cell carcinoma: an analysis of tumor invasive characteristics and risk.
    Yoder BJ; Rufforny I; Massoll NA; Wilkinson EJ
    Am J Surg Pathol; 2008 May; 32(5):765-72. PubMed ID: 18379417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of reduced tumor-free margin distance on long-term survival in FIGO stage IB/II vulvar squamous cell carcinoma.
    Micheletti L; Preti M; Cintolesi V; Corvetto E; Privitera S; Palmese E; Benedetto C
    J Gynecol Oncol; 2018 Sep; 29(5):e61. PubMed ID: 30022627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphovascular invasion and p16 expression are independent prognostic factors in stage I vulvar squamous cell carcinoma.
    Davidson B; Skeie-Jensen T; Holth A; Lindemann K; Toralba Barrameda AM; Lie AK; Wang Y
    Virchows Arch; 2024 Jun; 484(6):951-963. PubMed ID: 37843640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance and prognostic value of femoral lymph node metastasis in FIGO stage III vulvar carcinoma.
    Tu H; Sun P; Gu HF; Zhang XK; Huang H; Wan T; Liu JH
    Eur J Surg Oncol; 2017 Sep; 43(9):1768-1775. PubMed ID: 28602173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of recurrence and disease-free survival in advanced squamous cell carcinoma of the vulva.
    Lataifeh I; Nascimento MC; Nicklin JL; Perrin LC; Crandon AJ; Obermair A
    Gynecol Oncol; 2004 Dec; 95(3):701-5. PubMed ID: 15581985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invasive squamous cell carcinoma of the vulva: behaviour and results in the light of changing management regimens. A review of clinicohistological features predictive of regional lymph node involvement and local recurrence.
    Lingard D; Free K; Wright RG; Battistutta D
    Aust N Z J Obstet Gynaecol; 1992 May; 32(2):137-45. PubMed ID: 1520199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective analysis of surgically treated cases of squamous cell carcinoma vulva.
    Singhal S; Kumar S; Sharma DN; Bharti J; Meena J; Yadav A
    J Cancer Res Ther; 2021; 17(1):186-190. PubMed ID: 33723153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of first recurrence and outcomes in surgically treated women with vulvar cancer: results from FRANCOGYN study group.
    Pirot F; Chaltiel D; Ouldamer L; Touboul C; Raimond E; Carcopino X; Daraï E; Bendifallah S
    J Gynecol Obstet Hum Reprod; 2020 Nov; 49(9):101775. PubMed ID: 32438137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of adjuvant radiation or re-excision for early stage vulvar squamous cell carcinoma with positive or close surgical margins.
    Bedell SM; Hedberg C; Griffin A; Pearson H; Wilhite A; Rubin N; Erickson BK
    Gynecol Oncol; 2019 Aug; 154(2):276-279. PubMed ID: 31171409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The overexpression of p16 is not a surrogate marker for high-risk human papilloma virus genotypes and predicts clinical outcomes for vulvar cancer.
    Sznurkowski JJ; Żawrocki A; Biernat W
    BMC Cancer; 2016 Jul; 16():465. PubMed ID: 27411473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age, treatment and prognosis of patients with squamous cell vulvar cancer (VSCC) - analysis of the AGO-CaRE-1 study.
    Prieske K; Woelber L; Muallem MZ; Eulenburg C; Jueckstock JK; Hilpert F; de Gregorio N; Iborra S; Ignatov A; Hillemanns P; Fuerst S; Strauss HG; Baumann K; Beckmann M; Mustea A; Meier W; Harter P; Wimberger P; Sehouli J; Mahner S
    Gynecol Oncol; 2021 May; 161(2):442-448. PubMed ID: 33648748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of tumour-free margin distance for loco-regional control in vulvar cancer-a subset analysis of the Arbeitsgemeinschaft Gynäkologische Onkologie CaRE-1 multicenter study.
    Woelber L; Griebel LF; Eulenburg C; Sehouli J; Jueckstock J; Hilpert F; de Gregorio N; Hasenburg A; Ignatov A; Hillemanns P; Fuerst S; Strauss HG; Baumann KH; Thiel FC; Mustea A; Meier W; Harter P; Wimberger P; Hanker LC; Schmalfeldt B; Canzler U; Fehm T; Luyten A; Hellriegel M; Kosse J; Heiss C; Hantschmann P; Mallmann P; Tanner B; Pfisterer J; Richter B; Neuser P; Mahner S
    Eur J Cancer; 2016 Dec; 69():180-188. PubMed ID: 27837710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of lymph node variables in squamous cell carcinoma of the vulva.
    Paladini D; Cross P; Lopes A; Monaghan JM
    Cancer; 1994 Nov; 74(9):2491-6. PubMed ID: 7923005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical margins in squamous cell carcinoma, different for the vulva?
    Pleunis N; Leermakers MEJ; van der Wurff AA; Klinkhamer PJJM; Ezendam NPM; Boll D; de Hullu JA; Pijnenborg JMA
    Eur J Surg Oncol; 2018 Oct; 44(10):1555-1561. PubMed ID: 29934053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.